"The controlled-release formulation extends our patent protection to 2012 and represents an opportunity to continue to expand our market potential for zileuton by offering a more convenient dosing ...
Between April 2005 and December 2005, 216 patients (142 inpatients and 74 outpatients) from ten hospitals were enrolled. There were 126 male and 90 female patients (a ratio of 1.4:1). Of the 216 ...
https://www.thehindubusinessline.com/news/science/researchers-develop-controlled-release-oral-tablet-for-kala-azar-fungal-infections/article29221280.ece Copy ...
The abstract is available on the ObesityWeek website and can be accessed directly here. About Diazoxide Choline Controlled-Release (DCCR) TabletDiazoxide Choline Controlled-Release tablet is a novel, ...
The Oral Controlled Release Drug Delivery Technology Market is anticipated to increase from US$ 34.1 billion in 2022 to US$ 68.4 billion by 2032. During the forecast period (2022 to 2032), the overall ...
The median duration of treatment was substantially longer with tapentadol ER (268 days) than with oxycodone CR (59 days), and the incidence of overall gastrointestinal treatment-emergent adverse ...
Background and Objective: Oxycodone is a semisynthetic opioid analgesic drug classed as a strong opioid. The controlled-release oxycodone tablet formulation (OCRT) was approved in China in 2004 for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results